Yosuke Minami

18PUBLICATIONS
71CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cell and nuclear divisionMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 01, 2026
Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study.

|Aug 14, 2026
ELTS score and early "warning" define a 2-stage risk framework for failure-free survival in chronic-phase CML.

|Jun 18, 2026
Treatment-free remission and immune profiling after frontline second-generation TKI therapy in CML.

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Apr 29, 2026
Population-Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole-Genome Sequencing in Japan.

|Mar 31, 2026
Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 study.

Fumiya Ogasawara, Yosuke Minami, SungGi Chi

Pageof 3

Frequent Collaborators

5 joint publications

Naoto Takahashi

5 joint publications

Takaaki Ono

4 joint publications

Emiko Sakaida

4 joint publications

Yoshiko Atsuta